MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 186 filers reported holding MEDICINES CO in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $252,000 | -19.5% | 9,009 | +40.8% | 0.03% | +52.9% |
Q1 2017 | $313,000 | +44.2% | 6,400 | -6.4% | 0.02% | +21.4% |
Q1 2016 | $217,000 | -71.4% | 6,840 | -66.4% | 0.01% | -62.2% |
Q4 2015 | $759,000 | +14.3% | 20,340 | +16.4% | 0.04% | +12.1% |
Q3 2015 | $664,000 | -6.6% | 17,481 | -29.6% | 0.03% | +22.2% |
Q2 2015 | $711,000 | -74.9% | 24,845 | -75.4% | 0.03% | -75.9% |
Q1 2015 | $2,829,000 | +992.3% | 100,978 | +1007.7% | 0.11% | +522.2% |
Q1 2014 | $259,000 | +24.5% | 9,116 | +69.6% | 0.02% | +12.5% |
Q4 2013 | $208,000 | -69.7% | 5,376 | -73.7% | 0.02% | -70.4% |
Q3 2013 | $686,000 | +49.8% | 20,468 | +37.5% | 0.05% | 0.0% |
Q2 2013 | $458,000 | – | 14,888 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |